Live feed08:00:00·103dPRReleaseBenitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of ResponseBNTC· Benitec Biopharma Inc.Health CareOriginal source
